Global Diabetes Devices Market is expected to grow at a decent rate of ~6% by 2026 and is likely to Stay Resilient Through the Recession (2022-2023)
November 23, 2022 09:15 ET
|
Medi-Tech Insights
BRUSSELS, Belgium, Nov. 23, 2022 (GLOBE NEWSWIRE) -- Diabetes devices are devices that measure the blood glucose level in the body at regular intervals. Many types of devices fall under the category...
The Worldwide Diabetes Therapeutics Industry is Projected to Reach $3.3 Billion by 2030
October 12, 2022 07:33 ET
|
Research and Markets
Dublin, Oct. 12, 2022 (GLOBE NEWSWIRE) -- The "Diabetes Therapeutics Market By Product: Global Opportunity Analysis and Industry Forecast, 2020-2030" report has been added to ...
Smart Insulin Pens Global Market to Reach $214.05 Million by 2027 at a CAGR of 12.81%
October 11, 2022 08:48 ET
|
Research and Markets
Dublin, Oct. 11, 2022 (GLOBE NEWSWIRE) -- The "Smart Insulin Pens Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027" report has been added to ...
Insights on the Rapid Acting Insulin Global Market to 2027 - by Product, Indication, Distribution Channel and Region
August 22, 2022 08:43 ET
|
Research and Markets
Dublin, Aug. 22, 2022 (GLOBE NEWSWIRE) -- The "Rapid Acting Insulin Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027" report has been added to...
Global Human Insulin Market (2022 to 2027) - Industry Trends, Share, Size, Growth, Opportunity and Forecasts
July 15, 2022 06:03 ET
|
Research and Markets
Dublin, July 15, 2022 (GLOBE NEWSWIRE) -- The "Human Insulin Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027" report has been added to...
APAC Insulin Syringes Industry to 2027 - Players Include Novo Nordisk, Biocon, Eli Lilly and Company and Abbott Laboratories
May 24, 2022 05:58 ET
|
Research and Markets
Dublin, May 24, 2022 (GLOBE NEWSWIRE) -- The "Asia Pacific Insulin Syringes Market Size, Share & Industry Trends Analysis Report By Disease (Type 2 Diabetes and Type 1 Diabetes), By Syringe...
LAMEA Insulin Syringes Market (2021 to 2027) - Size, Share & Industry Trends Analysis Report
May 18, 2022 05:33 ET
|
Research and Markets
Dublin, May 18, 2022 (GLOBE NEWSWIRE) -- The "LAMEA Insulin Syringes Market Size, By Disease (Type 2 Diabetes and Type 1 Diabetes), By Syringe Size, By End User, By Country and Growth Forecast,...
Global Diabetes Pipeline Landscape Insights Report, 2021 - Featuring Emerging Drugs Tirzepatide, ORMD-0801, Ladarixin, Enavogliflozin, and DBPR-108
November 26, 2021 07:53 ET
|
Research and Markets
Dublin, Nov. 26, 2021 (GLOBE NEWSWIRE) -- The "Diabetes - Pipeline Insight, 2021" clinical trials has been added to ResearchAndMarkets.com's offering. This report provides comprehensive insights...
Insights on the Rapid Acting Insulin Global Market to 2027 - by Product Type, Indication, Distribution Channel and Regional Outlook
July 22, 2021 07:38 ET
|
Research and Markets
Dublin, July 22, 2021 (GLOBE NEWSWIRE) -- The "Global Rapid Acting Insulin Market By Product Type, By Indication, By Distribution Channel, By Regional Outlook, Industry Analysis Report and Forecast,...
Worldwide Human Insulin Industry to 2026 - Key Players Include Biocon, Novo Nordisk and Pfizer Among Others
July 14, 2021 08:08 ET
|
Research and Markets
Dublin, July 14, 2021 (GLOBE NEWSWIRE) -- The "Human Insulin Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021-2026" report has been added to...